Clinical Trials Browser

Phase 2 × Triple Negative Breast Neoplasms × Celecoxib × Clear all

NCT07104266 2025-08-05

Triple Negative Breast Cancer and Celecoxib. Pilot Study

Phase 2 Recruiting

Triple Negative Breast Neoplasms